• Home
  • Medical Devices
2023-2029 Global Full-length Transcriptome Sequencing Industry Research & Trends Analysis Report

2023-2029 Global Full-length Transcriptome Sequencing Industry Research & Trends Analysis Report

Report Code: KNJ1587607 | No. of Pages: 135 | Category: Medical Devices
Publisher: YH Research | Date of Publish: Mar-2023 
According to YH Research, the global market for Full-length Transcriptome Sequencing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Full-length Transcriptome Sequencing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Full-length Transcriptome Sequencing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Total RNA segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Biomedical Field has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Full-length Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Eurofins Scientific, Azenta, LabCorp and BGI Genomics, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Full-length Transcriptome Sequencing. Report Highlights:
(1) Global Full-length Transcriptome Sequencing market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Full-length Transcriptome Sequencing market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Full-length Transcriptome Sequencing market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Full-length Transcriptome Sequencing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Full-length Transcriptome Sequencing segment by type and by application and regional segment by type and by application.
(6) Full-length Transcriptome Sequencing industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa
Market segment by type, covers
    Total RNA
    Noncoding RNA
Market segment by application, can be divided into
    Biomedical Field
    Non-medical Field
Market segment by players, this report covers
    Illumina
    Thermo Fisher Scientific
    Bio-Rad
    Agilent Technologies
    QIAGEN
    Eurofins Scientific
    Azenta
    LabCorp
    BGI Genomics
1 Market Overview
    1.1 Product Overview and Scope of Full-length Transcriptome Sequencing
    1.2 Global Full-length Transcriptome Sequencing Market Size and Forecast
    1.3 China Full-length Transcriptome Sequencing Market Size and Forecast
    1.4 China Market Percentage in Global
        1.4.1 By Revenue, China Full-length Transcriptome Sequencing Share in Global Market, 2018-2029
        1.4.2 Full-length Transcriptome Sequencing Market Size: China VS Global, 2018-2029
    1.5 Full-length Transcriptome Sequencing Market Dynamics
        1.5.1 Full-length Transcriptome Sequencing Market Drivers
        1.5.2 Full-length Transcriptome Sequencing Market Restraints
        1.5.3 Full-length Transcriptome Sequencing Industry Trends
        1.5.4 Full-length Transcriptome Sequencing Industry Policy
2 Global Competitive Situation by Company
    2.1 Global Full-length Transcriptome Sequencing Revenue by Company (2018-2023)
    2.2 Global Full-length Transcriptome Sequencing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
    2.3 Global Full-length Transcriptome Sequencing Concentration Ratio
    2.4 Global Full-length Transcriptome Sequencing Mergers & Acquisitions, Expansion Plans
    2.5 Global Full-length Transcriptome Sequencing Manufacturers Product Type
3 China Competitive Situation by Company
    3.1 China Full-length Transcriptome Sequencing Revenue by Company (2018-2023)
    3.2 China Full-length Transcriptome Sequencing Full-length Transcriptome Sequencing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
    3.3 China Full-length Transcriptome Sequencing, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
    4.1 Full-length Transcriptome Sequencing Industry Chain
    4.2 Full-length Transcriptome Sequencing Upstream Analysis
    4.3 Full-length Transcriptome Sequencing Midstream Analysis
    4.4 Full-length Transcriptome Sequencing Downstream Analysis
5 Sights by Type
    5.1 Full-length Transcriptome Sequencing Classification
        5.1.1 Total RNA
        5.1.2 Noncoding RNA
    5.2 By Type, Global Full-length Transcriptome Sequencing Market Size & CAGR, 2018 VS 2022 VS 2029
    5.3 By Type, Global Full-length Transcriptome Sequencing Revenue, 2018-2029
6 Sights by Application
    6.1 Full-length Transcriptome Sequencing Segment by Application
        6.1.1 Biomedical Field
        6.1.2 Non-medical Field
    6.2 By Application, Global Full-length Transcriptome Sequencing Market Size & CAGR, 2018 VS 2022 VS 2029
    6.3 By Application, Global Full-length Transcriptome Sequencing Revenue, 2018-2029
7 Sales Sights by Region
    7.1 By Region, Global Full-length Transcriptome Sequencing Market Size, 2018 VS 2022 VS 2029
    7.2 By Region, Global Full-length Transcriptome Sequencing Market Size, 2018-2029
    7.3 North America
        7.3.1 North America Full-length Transcriptome Sequencing Market Size & Forecasts, 2018-2029
        7.3.2 By Country, North America Full-length Transcriptome Sequencing Market Size Market Share
    7.4 Europe
        7.4.1 Europe Full-length Transcriptome Sequencing Market Size & Forecasts, 2018-2029
        7.4.2 By Country, Europe Full-length Transcriptome Sequencing Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Full-length Transcriptome Sequencing Market Size & Forecasts, 2018-2029
        7.5.2 By Country/Region, Asia Pacific Full-length Transcriptome Sequencing Market Size Market Share
    7.6 South America
        7.6.1 South America Full-length Transcriptome Sequencing Market Size & Forecasts, 2018-2029
        7.6.2 By Country, South America Full-length Transcriptome Sequencing Market Size Market Share
    7.7 Middle East & Africa
8 Sights by Country Level
    8.1 By Country, Global Full-length Transcriptome Sequencing Market Size & CAGR，2018 VS 2022 VS 2029
    8.2 By Country, Global Full-length Transcriptome Sequencing Market Size, 2018-2029
    8.3 U.S.
        8.3.1 U.S. Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.3.2 By Company, U.S. Full-length Transcriptome Sequencing Revenue Market Share, 2018-2023
        8.3.3 By Type, U.S. Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
        8.3.4 By Application, U.S. Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
    8.4 Europe
        8.4.1 Europe Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.4.2 By Company, Europe Full-length Transcriptome Sequencing Revenue Market Share, 2018-2023
        8.4.3 By Type, Europe Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
        8.4.4 By Application, Europe Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
    8.5 China
        8.5.1 China Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.5.2 By Company, China Full-length Transcriptome Sequencing Revenue Market Share, 2018-2023
        8.5.3 By Type, China Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
        8.5.4 By Application, China Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
    8.6 Japan
        8.6.1 Japan Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.6.2 By Company, Japan Full-length Transcriptome Sequencing Revenue Market Share, 2018-2023
        8.6.3 By Type, Japan Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
        8.6.4 By Application, Japan Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
    8.7 South Korea
        8.7.1 South Korea Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.7.2 By Company, South Korea Full-length Transcriptome Sequencing Revenue Market Share, 2018-2023
        8.7.3 By Type, South Korea Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
        8.7.4 By Application, South Korea Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
    8.8 Southeast Asia
        8.8.1 Southeast Asia Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.8.2 By Company, Southeast Asia Full-length Transcriptome Sequencing Revenue Market Share, 2018-2023
        8.8.3 By Type, Southeast Asia Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
        8.8.4 By Application, Southeast Asia Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
    8.9 India
        8.9.1 India Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.9.2 By Company, India Full-length Transcriptome Sequencing Revenue Market Share, 2018-2023
        8.9.3 By Type, India Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
        8.9.4 By Application, India Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
    8.10 Middle East & Asia
        8.10.1 Middle East & Asia Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.10.2 By Company, Middle East & Asia Full-length Transcriptome Sequencing Revenue Market Share, 2018-2023
        8.10.3 By Type, Middle East & Asia Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
        8.10.4 By Application, Middle East & Asia Full-length Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
    9.1 Illumina
        9.1.1 Illumina Company Information, Head Office, Market Area and Industry Position
        9.1.2 Illumina Company Profile and Main Business
        9.1.3 Illumina Full-length Transcriptome Sequencing Models, Specifications and Application
        9.1.4 Illumina Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.1.5 Illumina Recent Developments
    9.2 Thermo Fisher Scientific
        9.2.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
        9.2.2 Thermo Fisher Scientific Company Profile and Main Business
        9.2.3 Thermo Fisher Scientific Full-length Transcriptome Sequencing Models, Specifications and Application
        9.2.4 Thermo Fisher Scientific Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.2.5 Thermo Fisher Scientific Recent Developments
    9.3 Bio-Rad
        9.3.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
        9.3.2 Bio-Rad Company Profile and Main Business
        9.3.3 Bio-Rad Full-length Transcriptome Sequencing Models, Specifications and Application
        9.3.4 Bio-Rad Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.3.5 Bio-Rad Recent Developments
    9.4 Agilent Technologies
        9.4.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position
        9.4.2 Agilent Technologies Company Profile and Main Business
        9.4.3 Agilent Technologies Full-length Transcriptome Sequencing Models, Specifications and Application
        9.4.4 Agilent Technologies Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.4.5 Agilent Technologies Recent Developments
    9.5 QIAGEN
        9.5.1 QIAGEN Company Information, Head Office, Market Area and Industry Position
        9.5.2 QIAGEN Company Profile and Main Business
        9.5.3 QIAGEN Full-length Transcriptome Sequencing Models, Specifications and Application
        9.5.4 QIAGEN Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.5.5 QIAGEN Recent Developments
    9.6 Eurofins Scientific
        9.6.1 Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
        9.6.2 Eurofins Scientific Company Profile and Main Business
        9.6.3 Eurofins Scientific Full-length Transcriptome Sequencing Models, Specifications and Application
        9.6.4 Eurofins Scientific Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.6.5 Eurofins Scientific Recent Developments
    9.7 Azenta
        9.7.1 Azenta Company Information, Head Office, Market Area and Industry Position
        9.7.2 Azenta Company Profile and Main Business
        9.7.3 Azenta Full-length Transcriptome Sequencing Models, Specifications and Application
        9.7.4 Azenta Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.7.5 Azenta Recent Developments
    9.8 LabCorp
        9.8.1 LabCorp Company Information, Head Office, Market Area and Industry Position
        9.8.2 LabCorp Company Profile and Main Business
        9.8.3 LabCorp Full-length Transcriptome Sequencing Models, Specifications and Application
        9.8.4 LabCorp Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.8.5 LabCorp Recent Developments
    9.9 BGI Genomics
        9.9.1 BGI Genomics Company Information, Head Office, Market Area and Industry Position
        9.9.2 BGI Genomics Company Profile and Main Business
        9.9.3 BGI Genomics Full-length Transcriptome Sequencing Models, Specifications and Application
        9.9.4 BGI Genomics Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.9.5 BGI Genomics Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com